Clinical colorectal cancer

publication venue for

Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence. 2011
Collision tumor of the large bowel in the context of advanced pregnancy and ulcerative colitis. 2008
Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma. 2008
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study. 2022
Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol. 2021
Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study.. 20. 2020
Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis.. 19. 2020
Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer.. 18. 2019
Rising Proportion of Young Individuals With Rectal and Colon Cancer.. 18. 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.. 18. 2018
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?. 17. 2018
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.. 17. 2018
Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.. 17. 2018
Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer.. 16. 2017
Molecular Screening for Lynch Syndrome in Young Patients With Colorectal Adenomas.. 16. 2017
Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.. 15. 2016
Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.. 15. 2016
A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer.. 15. 2016
Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications.. 15. 2015
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.. 14. 2015
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma.. 14. 2015
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer.. 13. 2014
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.. 13. 2013
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance.. 12. 2013
Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.. 12. 2013
Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.. 12. 2013
Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies.. 12. 2012
Treatment of pulmonary colorectal metastases by radiofrequency ablation.. 12. 2012
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized.. 11. 2012
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.. 11. 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma.. 9. 2010
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer.. 9. 2010
Prospective immunohistochemical analysis of primary colorectal cancers for loss of mismatch repair protein expression.. 9. 2010
Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders.. 5. 2006
Upper gastrointestinal malignancies: a new era in clinical colorectal cancer.. 8. 2009
Local excision for rectal carcinoma. 2008
Regional chemotherapy for liver-limited metastatic colorectal cancer. 2008
Second-line management of metastatic colorectal cancer. 2008
Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. 2005
A current perspective on local excision of rectal cancer. 2004
Diagnosing hereditary colorectal cancer. 2010
Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer. 2004

VIVO Weill Cornell Medical College

Clinical colorectal cancer Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)